BASKING RIDGE, N.J.--(BUSINESS WIRE)--Ipsen’s (Euronext: IPN; ADR: IPSEY) North American Operations subsidiary, Ipsen Biopharmaceuticals Inc., today announced its commitment to award up to $300,000 in grants to the Dystonia Medical Research Foundation’s (DMRF) 2013 Clinical Fellowship Training Program. The Company’s contribution will provide up to four one-year fellowship grants, at $75,000 each, to address current challenges for physicians in the evaluation and treatment of dystonia – a neurological movement disorder that causes involuntary muscle spasms.
